FDA officials responsible for the a...

FDA officials responsible for the agency's fit clinical practices (GCP) program emphasize that hardly any if any, GCP-related areas generate as abundant industry uncertainty as the Form FDA 1572--Statement of Investigator. end this seemingly mundane form, a clinical investigator must provide a meditation sponsor with information on the education, training, and experience that qualities him/her to management a particular study as well as his/her commitment to guidance the proposed study in accordance with the protocol and federal regulations.

throughout the years, several factors have contributed